In vitro degradation rate of apatitic calcium phosphate cement with incorporated PLGA microspheres

Acta Biomaterialia

Volumn 7, Issue 9, 2011, Pages 3459-3468

  Felix Lanao R P ^a   Leeuwenburgh, S C G ^a   Wolke, J G C ^a   Jansen, J A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Calcium phosphate cement; Degradation; In vitro; Microspheres; PLGA

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADATION; BONE; BONE CEMENT; CALCIUM PHOSPHATE; CEMENTS; DEGRADATION; POLYMERIC IMPLANTS;

APATITIC CALCIUM PHOSPHATES; CALCIUM PHOSPHATE CEMENT; CEMENT DEGRADATIONS; CHEMICAL CHARACTERISTIC; DEGRADATION RATE; IN-VITRO; MACRO-POROSITY; PLGA; PLGA MICROSPHERES; POROGENS;

MICROSPHERES;

APATITE; APATITIC CALCIUM PHOSPHATE CEMENT; CALCIUM PHOSPHATE CERAMIC; MICROSPHERE; POLYGLACTIN; POROGEN; UNCLASSIFIED DRUG;

ACIDITY; ARTICLE; CHEMICAL PARAMETERS; CHEMICAL STRUCTURE; COMPOSITE MATERIAL; DEGRADATION KINETICS; MICRO-COMPUTED TOMOGRAPHY; MOLECULAR WEIGHT; POROSITY; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCANNING ELECTRON MICROSCOPY;

EID: 79961015788     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2011.05.036     Document Type: Article

References (46)

1. Habraken WJ, Wolke JG, Jansen JA. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007;59(4-5):234-45.
2. Sanzana ES, Navarro M, Macule F, Suso S, Planell JA, Ginebra MP. Of the in vivo behavior of calcium phosphate cements and glasses as bone substitutes. Acta Biomater 2010;4(6):1924-33.
3. Zhang Y, Xu HH, Takagi S, Chow LC. In situ hardening hydroxyapatite-based scaffold for bone repair. J Mater Sci Mater Med 2006;17:437-45.
4. Takagi S, Chow LC. Formation of macropores in calcium phosphate cement implants. J Mater Sci Mater Med 2001;12:135-9. (Pubitemid 32178863)
5. Xu HH, Quinn JB, Takagi S, Chow LC, Eichmiller FC. Strong and macroporous calcium phosphate cement: effects of porosity and fiber reinforcement on mechanical properties. J Biomed Mater Res 2001;57:457-66. (Pubitemid 32885277)
6. Tajima S, Kishi Y, Oda M, Maruta M, Matsuya S, Ishikawa K. Fabrication of biporous low-crystalline apatite based on mannitol dissolution from apatite cement. Dent Mater J 2006;25:616-20. (Pubitemid 44891341)
7. Barralet JE, Grover L, Gaunt T, Wright AJ, Gibson IR. Preparation of macroporous calcium phosphate cement tissue engineering scaffold. Biomaterials 2002;23:3063-72. (Pubitemid 34522119)
8. Gangfeng H, Xiao L, Fu H, Bi D, Ma H, Tong P. Degradable and bioactive scaffold of calcium phosphate and calcium sulphate from self-setting cement for bone regeneration. J Porous Mater 2009;17(5):605-13.
9. del Real RP, Wolke JG, Vallet-Regi M, Jansen JA. A new method to produce macropores in calcium phosphate cements. Biomaterials 2002;23:3673-80. (Pubitemid 34626570)
10. Almirall A, Larrecq G, Delgado JA, Martínez S, Planell JA, Ginebra MP. Fabrication of low temperature macroporous hydroxyapatite scaffolds by foaming and hydrolysis of an alpha-TCP paste. Biomaterials 2004;25(17):3671-80. (Pubitemid 38331992)
11. del Valle S, Miño N, Muñoz F, González A, Planell JA, Ginebra MP. In vivo evaluation of an injectable macroporous calcium phosphate cement. J Mater Sci Mater Med 2007;18(2):353-61.
12. del Real RP, Ooms E, Wolke JG, Vallet-Regi M, Jansen JA. In vivo bone response to porous calcium phosphate cement. J Biomed Mater Res A 2003;65: 30-6.
13. Lian Q, Li DC, He JK, Wang Z. Mechanical properties and in vivo performance of calcium phosphate cement-chitosan fibre composite. Proc Inst Mech Eng H 2008;222:347-53.
14. Girod Fullana S, Ternet H, Freche M, Lacout JL, Rodriguez F. Controlled release properties and final macroporosity of a pectin microspheres-calcium phosphate composite bone cement. Acta Biomater 2010;6:2294-300.
15. Habraken WJ, Zhang Z, Wolke JG, Grijpma DW, Mikos AG, Feijen J, et al. Introduction of enzymatically degradable poly(trimethylene carbonate) microspheres into an injectable calcium phosphate cement. Biomaterials 2008;29:2464-76.
16. LeGeros RZ. Biodegradation and bioresorption of calcium phosphate ceramics. Clin Mater 1993;14:65-88.
17. Athanasiou KA, Niederauer GC, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 1996;17:93-102. (Pubitemid 26031365)
18. Iwasaki Y, Sawada S, Ishihara K, Khang G, Lee HB. Reduction of surface-induced inflammatory reaction on PLGA/MPC polymer blend. Biomaterials 2002;18:3897-903. (Pubitemid 34828163)
19. Kang SW, Yang HS, Seo SW, Han DK, Kim BS. Apatite-coated poly(lactic-coglycolic acid) microspheres as an injectable scaffold for bone tissue engineering. J Biomed Mater Res A 2008;85:747-56. (Pubitemid 351632888)
20. Li J, Beaussart A, Chen Y, Mak AF. Transfer of apatite coating from porogens to scaffolds: uniform apatite coating within porous poly(DL-lactic-co-glycolic acid) scaffold in vitro. J Biomed Mater Res A 2007;80:226-33. (Pubitemid 44913350)
21. Lu L, Peter SJ, Lyman MD, Lai HL, Leite SM, Tamada JA, et al. In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials 2000;21:1837-45.
22. Heller J, Hoffman AS. Drug delivery systems. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, editors. Biomaterials science, an introduction to materials in medicine. New York: Elsevier Academic Press; 2004. p. 629-49.
23. Cam D, Hyon S, Ikada Y. Degradation of high molecular weight poly(L-lactide) in alkaline medium. Biomaterials 1995;16(11):833-43.
24. Wu XS, Wang N. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. Part II: Biodegradation. J Biomater Sci Polym Ed 2001;12(1):21-34.
25. Houchin ML, Topp EM. Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms. J Pharm Sci 2008;97: 2395-404.
26. Tracy MA, Ward KL, Firouzabadian L, Wang Y, Dong N, Qian R, et al. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. Biomaterials 1999;20:1057-62. (Pubitemid 29229474)
27. Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997;28:5-24. (Pubitemid 27497671)
28. Alexis F. Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)]. Polym Int 2005;54:36-46. (Pubitemid 40032749)
29. Komlev VS, Barinov SM. Porous hydroxyapatite ceramics of bi-modal pore size distribution. J Mater Sci Mater Med 2002;13:295-9. (Pubitemid 34234037)
30. Simon JL, Rekow ED, Thompson VP, Beam H, Ricci JL, Parsons JR. microCT analysis of hydroxyapatite bone repair scaffolds created via three-dimensional printing for evaluating the effects of scaffold architecture on bone ingrowth. J Biomed Mater Res A 2008;85:371-7. (Pubitemid 351535318)
31. Liao H, Walboomers XF, Habraken WJ, Zhang Z, Li Y, Grijpma DW, et al. Injectable calcium phosphate cement with PLGA, gelatin and PTMC microspheres in a rabbit femoral defect. Acta Biomater 2011;7(4):1752-9.
32. Habraken WJ, Wolke JG, Mikos AG, Jansen JA. Injectable PLGA microsphere/ calcium phosphate cements: physical properties and degradation characteristics. J Biomater Sci Polym Ed 2006;17:1057-74. (Pubitemid 44559975)
33. Spenlehauer G, Vert M, Benoit JP, Boddaert A. In vitro and in vivo degradation of poly(D,L lactide/glycolide) type microspheres made by solvent evaporation method. Biomaterials 1989;10:557-63.
34. Vert M, Schwach G, Engel R, Coudane J. Something new in the field of PLA/GA bioresorbable polymers? J Control Release 1998;30:85-92.
35. Wang N, Qiu JS, Wu XS. Tailored polymeric materials for controlled delivery systems. ACS Symp Ser 1988;709:242-54.
36. Park TG. Degradation of poly(D,L-lactic acid) microspheres: effect of molecular weight. J Control Release 1994;30:161-73.
37. Wiggins JS. Hydrolytic degradation of poly(D,L-lactide) as a function of end group: carboxylic acid vs. hydroxyl. Polymer 2006;47(6):1960-9. (Pubitemid 43344370)
38. Qi X, Ye J, Wang Y. Improved injectability and in vitro degradation of a calcium phosphate cement containing poly(lactide-co-glycolide) microspheres. Acta Biomater 2008;4(6):1837-45.
39. Fei Z, Hu Y, Wu D, Wu H, Lu R, Bai J, et al. Preparation and property of a novel bone graft composite consisting of rhBMP-2 loaded PLGA microspheres and calcium phosphate cement. J Mater Sci: Mater Med 2008;19:1109-16. (Pubitemid 351337469)
40. Plachokova A, Link D, van den Dolder J, van den Beucken J, Jansen J. Bone regenerative properties of injectable PGLA-CaP composite with TGF-beta1 in a rat augmentation model. J Tissue Eng Regen Med 2007;1(6):457-64.
41. Ruhé PQ, Hedberg EL, Padron NT, Spauwen PH, Jansen JA, Mikos AG. Biocompatibility and degradation of poly(DL-lactic-co-glycolic acid)/calcium phosphate cement composites. J Biomed Mater Res A 2005;74(4):533-44. (Pubitemid 41216255)
42. Bodde EW, Boerman OC, Russel FG, Mikos AG, Spauwen PH, Jansen JA. The kinetic and biological activity of different loaded rhBMP-2 calcium phosphate cement implants in rats. J Biomed Mater Res A 2008;87(3):780-91.
43. Bodde EW, Habraken WJ, Mikos AG, Spauwen PH, Jansen JA. Effect of polymer molecular weight on the bone biological activity of biodegradable polymer/ calcium phosphate cement composites. Tissue Eng Part A 2009;15(10):3183-91.
44. Zolnik BS, Burgess DJ. Effect of acidic pH on PLGA microsphere degradation and release. J Control Release 2007;122:338-44. (Pubitemid 47404676)
45. Liu H, Slamovich EB, Webster TJ. Less harmful acidic degradation of poly(lactic-co-glycolic acid) bone tissue engineering scaffolds through titania nanoparticle addition. Int J Nanomed 2006;1:541-5.
46. Yoon SJ, Kim SH, Ha HJ, Ko YK, So JW, Kim MS, et al. Reduction of inflammatory reaction of poly(D,L-lactic-co-glycolic acid) using demineralized bone particles. Tissue Eng Part A 2008;14:539-47. (Pubitemid 351520462)